- Rechallenge with anti-EGFR therapy2023 | Third Faculty of Medicine
- Acute Conditioning of Antigen-Expanded CD8(+) T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge2020 | Second Faculty of Medicine
- Options and rationale for reinstituting anti-EGFR therapy in pretreated RAS wild-type advanced colorectal carcinomas2023 | Publication without faculty affiliation
- Possibilities and substantiation of re-treatment with anti-EGFR drugs for pre-treated RAS wild-type advanced colorectal cancers2021 | Publication without faculty affiliation
- Terlipressin Induced Severe Hyponatremia2016 | First Faculty of Medicine
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance The GAUSS-3 Randomized Clinical Trial2016 | First Faculty of Medicine
- Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach2022 | Publication without faculty affiliation
- Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition2020 | Second Faculty of Medicine
